Here’s a concise, up-to-date-in-principle overview of Celebrex (celecoxib). I don’t have real-time access to 2026 FDA labeling, but I’ll note what’s standard and how to get the exact current details.
What it is
- Celecoxib is a COX‑2 selective nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation.
- Brand name: Celebrex (generic celecoxib is available).
- Mechanism: Inhibits COX‑2 in joints to reduce prostaglandin-mediated pain and inflammation (with somewhat less GI irritation than nonselective NSAIDs, but not free of GI risk).
Common approved uses (indications)
- Osteoarthritis (OA)
- Rheumatoid arthritis (RA)
- Ankylosing spondylitis
- Juvenile idiopathic arthritis (JIA)
- Acute pain (including post-dental procedures)
- Primary dysmenorrhea (menstrual pain)
- Reduction of the number of colorectal polyps in adults with familial adenomatous polyposis (FAP) (this is a separate, specific indication for a subset of patients)
Note: Exact approved indications can vary by country and over time with labeling updates. Check the current label for your location.
Dosing (typical ranges; exact regimen should come from the current labeling)
- Dosing depends on condition (OA, RA, AS, JIA, dysmenorrhea, etc.) and patient factors.
- General guidance you may see: often in the range of 100–200 mg taken twice daily or 200 mg once daily, with adjustments based on response and tolerability. Some acute-dysmenorrhea regimens use a higher initial dose.
- Because dosing is condition- and patient-specific, always follow the current FDA labeling or your clinician’s instructions.
Key safety and warnings
- Boxed warning: Cardiovascular risk (heart attack, stroke) and gastrointestinal risk (bleeding, ulcers, perforation). The GI risk is generally lower than nonselective NSAIDs but not zero.
- Renal effects: Possible impairment or worsening of kidney function; monitor in people with kidney disease or dehydration.
- Allergic/hypersensitivity reactions: May occur, especially in people with a history of sulfa allergies (cross-reactivity is possible with celecoxib due to the sulfonamide group in the molecule).
- Pregnancy: Avoid in the later stages of pregnancy (risk to fetus); generally use only if clearly needed and after discussing with a clinician.
- Liver tests: Elevations in LFTs can occur; monitor if used long-term.
- Other cautions: Interactions with other NSAIDs, anticoagulants (e.g., warfarin), certain antidepressants, antihypertensives (blood pressure can be affected), and drugs affecting kidney function.
Common side effects
- GI upset (dyspepsia, abdominal pain), diarrhea, upset stomach
- Headache, dizziness
- Elevated blood pressure, edema
- Rare but serious: GI bleeding, liver enzyme elevations, severe skin reactions
Who should be especially cautious
- History of GI ulcers or bleeding
- Significant cardiovascular disease risk
- Kidney disease or dehydration
- Concurrent use of anticoagulants or other NSAIDs
- Pregnant individuals (especially in the third trimester)
Where to get the latest 2026 labeling and safety updates
- The most reliable current source is the FDA labeling (DailyMed entry for celecoxib). It includes indications, dosing, contraindications, warnings, adverse effects, and drug interactions.
- How to check: go to dailyMed (dailymed.nlm.nih.gov) and search for “celecoxib” or “Celebrex.” Look for the most recent “Highlights” and “Full Prescribing Information.”
- You can also check the manufacturer’s site and recent FDA safety communications for any new warnings or changes.
Would you like me to pull a current 2026 labeling summary from DailyMed and highlight any new warnings, dosing changes, or approved indications? If you’re treating a specific condition (OA, RA, dysmenorrhea, FAP polyp reduction, etc.) or a particular patient scenario (age, kidney function, pregnancy status, concomitant meds), tell me and I’ll tailor the summary.